Literature DB >> 1879993

Plasma morphine and morphine-6-glucuronide patterns in cancer patients after oral, subcutaneous, sublabial and rectal short-term administration.

M Breda1, M Bianchi, C Ripamonti, E Zecca, V Ventafridda, A E Panerai.   

Abstract

Clinical studies on the effectiveness of morphine administered through different routes are contradictory. In order to further elucidate this point, the plasma concentrations of morphine and its 3- and 6-glucuronated metabolites were measured after short-term oral, sublabial, rectal and subcutaneous administration of the opiate. The bioavailability of free morphine and the 6-glucuronated active metabolite was comparable through the different routes. It was concluded that the choice of the route of morphine administration should be mainly guided by the needs of each individual patient.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879993

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  3 in total

1.  The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.

Authors:  R Stuart-Harris; S P Joel; P McDonald; D Currow; M L Slevin
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

2.  Transdermal fentanyl in uncontrolled cancer pain: titration on a day-to-day basis as a procedure for safe and effective dose finding--a pilot study in 20 patients.

Authors:  W Korte; R Morant
Journal:  Support Care Cancer       Date:  1994-03       Impact factor: 3.603

3.  Opioid plasma concentration during switching from morphine to methadone: preliminary data.

Authors:  S Mercadante; M Bianchi; P Villari; P Ferrera; A Casuccio; F Fulfaro; V Gebbia
Journal:  Support Care Cancer       Date:  2003-04-03       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.